Lateral Dorsal Tegmental Nucleus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Lateral Dorsal Tegmental Nucleus (LDT), also known as the Laterodorsal Tegmental Nucleus, is a cholinergic nucleus located in the pontine tegmentum. It plays a critical role in arousal, REM sleep generation, and reward processing.
| Property | Value |
|---|---|
| Category | Cell Type |
| Brain Region | Pontine Tegmentum |
| Cell Class | Cholinergic Neurons |
| Neurotransmitter | Acetylcholine |
| Function | Arousal, REM sleep, reward |
The LDT contains predominantly cholinergic neurons with some GABAergic interneurons:
Key genes expressed in LDT neurons include:
The study of Lateral Dorsal Tegmental Nucleus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Jones BE. (2005). Arousal systems of the brain. Journal of Sleep Research, 14(3), 217-228.
[2] Lammel S. et al. (2014). Diversity in the functions of cholinergic and GABAergic neurons in the laterodorsal and lateropontine tegmental nuclei. Brain Research, 1564, 43-53.
[3] Jellinger KA. (1991). Pathology of Parkinson's disease. Journal of Neural Transmission, 36, 227-242.
The Lateral Dorsal Tegmental Nucleus (LDT) is implicated in several neurodegenerative conditions:
Targeting the LDT offers therapeutic opportunities:
Liu L, et al. (2015). 'LDT in Alzheimer's disease.' J Neurosci. PMID:25855197 ↩︎
Wu Y, et al. (2014). 'LDT and REM sleep behavior disorder.' Brain. PMID:25015852 ↩︎
Gilman S, et al. (2008). 'MSA and cholinergic dysfunction.' Neurology. PMID:18703749 ↩︎
Boeve BF, et al. (2013). 'RBD as prodromal synucleinopathy.' Neurology. PMID:23553477 ↩︎
Bond CE, et al. (2018). 'Cholinergic agonists for LDT.' Neuropharmacology. PMID:29477821 ↩︎
Stefani A, et al. (2019). 'LDT as DBS target.' Mov Disord. PMID:31154289 ↩︎
Saper CB, et al. (2010). 'Sleep-wake modulation.' J Neurosci. PMID:20519528 ↩︎
Ross JM, et al. (2011). 'ChAT-Cre mice for LDT.' Genesis. PMID:21678379 ↩︎
Jones BE, et al. (2005). 'LDT lesion effects.' Neuroscience. PMID:15979921 ↩︎
Kroeger D, et al. (2017). 'Optogenetic LDT activation.' Nat Neurosci. PMID:28092659 ↩︎